These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38918142)

  • 1. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria.
    Chen L; Kang Z; Shen J; Zhao R; Miao Y; Zhang L; Zheng Z; Zhang Z; Liu N; Wang C; Fang H; Zhou J; Wang Y; Liu Z; Yang Y; Chen Q
    Sci Bull (Beijing); 2024 Aug; 69(16):2565-2579. PubMed ID: 38918142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial tellurium-containing polycarbonate drug carriers to eliminate intratumor bacteria for synergetic chemotherapy against colorectal cancer.
    Hu J; Ran S; Huang Z; Liu Y; Hu H; Zhou Y; Ding X; Yin J; Zhang Y
    Acta Biomater; 2024 Sep; 185():323-335. PubMed ID: 38964527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-
    Cao Q; Zhou R; Guo S; Meng K; Yang X; Liu M; Ma B; Su C; Duan X
    Int J Nanomedicine; 2024; 19():9437-9458. PubMed ID: 39290859
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Biomimetic Autophagosomes-Based Nanovaccine Boosts Anticancer Immunity.
    Qu L; Cui G; Sun Y; Ye R; Sun Y; Meng F; Wang S; Zhong Z
    Adv Mater; 2024 Oct; 36(40):e2409590. PubMed ID: 39194369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells.
    Huang F; Zhao J; Wei Y; Wen Z; Zhang Y; Wang X; Shen Y; Wang LX; Pan N
    Int J Nanomedicine; 2020; 15():1021-1035. PubMed ID: 32103954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.
    Li T; Chen G; Lin L; Li B; Wang X; Chen Y; Huang W; Cai M; Xiao Z; Shuai X; Zhu K
    Biomaterials; 2024 Sep; 309():122626. PubMed ID: 38795524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubeimuside I improves the efficacy of a therapeutic
    Tong Y; Lu G; Wang Z; Hao S; Zhang G; Sun H
    Front Immunol; 2023; 14():1154818. PubMed ID: 37207216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
    Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
    Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines.
    Hu H; Yang C; Zhang F; Li M; Tu Z; Mu L; Dawulieti J; Lao YH; Xiao Z; Yan H; Sun W; Shao D; Leong KW
    Adv Sci (Weinh); 2021 Aug; 8(15):2002020. PubMed ID: 34386315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment.
    Wang Z; Miao F; Gu L; Zhang R; Ma Y; Li Y; Zheng J; Lin Z; Gao Y; Huang L; Shen Y; Wu T; Luo F; Li W
    ACS Nano; 2024 Sep; 18(35):24219-24235. PubMed ID: 39172516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
    Nakagawa T; Tanino T; Onishi M; Tofukuji S; Kanazawa T; Ishioka Y; Itoh T; Kugimiya A; Katayama K; Yamamoto T; Nagira M; Ishii KJ
    Front Immunol; 2021; 12():803090. PubMed ID: 35003132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
    Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
    J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
    Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
    ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanovaccine: an emerging strategy.
    Das A; Ali N
    Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.